Trial
NCT02960503
Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Vanderbilt University
Collaborators
—
Condition
Sickle Cell Disease
Intervention
Azithromycin
Why stopped
Key personnel moved to new location. Therefore, we had insufficient resources to initiate the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-02